(Q42690482)

English

Efficacy, tolerability, and effects on quality of life of inhaled salmeterol and oral theophylline in patients with mild-to-moderate chronic obstructive pulmonary disease. SLMT02 Italian Study Group.

scientific article published on November 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916607%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Efficacy, tolerability, and effects on quality of life of inhaled salmeterol and oral theophylline in patients with mild-to-moderate chronic obstructive pulmonary disease. SLMT02 Italian Study Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916607%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

chronic obstructive pulmonary disease

1 reference

based on heuristic

inferred from title

quality of life

1 reference

based on heuristic

inferred from title

Gabriele Di Lorenzo

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916607%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Pasquale Mansueto

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916607%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

author name string

G Morici

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916607%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

A Drago

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916607%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

M E Pellitteri

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916607%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

M Melluso

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916607%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

F Norrito

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916607%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

L Squassante

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916607%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

A Fasolo

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916607%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

publication date

1 November 1998

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916607%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Clinical Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916607%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916607%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916607%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1130-1148

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916607%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980109-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980109-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic algorithm for chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980109-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Beta-adrenergic receptors and their regulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980109-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of chronic obstructive pulmonary disease with orally administered theophylline. A double-blind, controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980109-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of theophylline in "irreversible" airflow obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980109-4

7 January 2021

based on heuristic

inferred from DOI database lookup

What role for theophylline?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980109-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Overnight theophylline concentrations and effects on sleep and lung function in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980109-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980109-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980109-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of salmeterol and formoterol in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980109-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980109-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of formoterol, salmeterol or oxitropium bromide on airway responses to salbutamol in COPD

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980109-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of the bronchodilating effects of salmeterol, salbutamol and ipratropium bromide in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980109-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Salmeterol and formoterol in partially reversible severe chronic obstructive pulmonary disease: a dose-response study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980109-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of inhaled salmeterol in the management of smokers with chronic obstructive pulmonary disease: a single centre randomised, double blind, placebo controlled, crossover study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980109-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of regular salmeterol on lung function and exercise capacity in patients with chronic obstructive airways disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980109-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The MOS short-form general health survey. Reliability and validity in a patient population

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980109-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980109-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect sizes for interpreting changes in health status.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980109-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute response to bronchodilator. An imperfect guide for bronchodilator therapy in chronic airflow limitation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980109-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose response relation to oral theophylline in severe chronic obstructive airways disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980109-4

7 January 2021

based on heuristic

inferred from DOI database lookup

In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone. An 85-day multicenter trial. COMBIVENT Inhalation Aerosol Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980109-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of theophylline on breathlessness and exercise tolerance in patients with chronic airflow obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980109-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Theophylline and Salbutamol Improve Pulmonary Function in Patients with Irreversible Chronic Obstructive Pulmonary Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980109-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980109-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(98)80109-4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916607%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916607%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42690482&oldid=1579135046"